Global Med Technologies(R) Extends Its Worldwide Outreach
September 13 2007 - 9:00AM
PR Newswire (US)
Caribbean Hospital Becomes Latest SafeTrace Tx(R) User DENVER,
Sept. 13 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) today announced that its Wyndgate
Technologies(R) division has licensed its Safe Trace Tx(R) software
to the Cardiovascular Center of Puerto Rico and the Caribbean
(CCPRC) to manage its transfusion service. Terms of the agreement
were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
SafeTrace Tx is a revolutionary software product designed to raise
the standard of care for patients, improve safety, reduce waste and
increase efficiency in the blood transfusion continuum. With the
number of surgeries performed by CCPRC, having an efficient
software system to manage transfusions is critical. CCPRC selected
the SafeTrace Tx system to interface with their Keane Laboratory
Information System because of Wyndgate's solid reputation and the
software's ability to enable CCPRC's staff to effectively manage
orders and blood product inventory, further enhancing patient care.
Will Willman, Wyndgate Technologies' Senior Vice-President of
International Business Development, stated, "We are very pleased to
be working with Cardiovascular Center of Puerto Rico and the
Caribbean, as well as partnering with Keane to provide CCPRC with
valuable laboratory solutions. CCPRC, a prestigious hospital, is
leading the way in cardiovascular care and providing treatments to
many patients with life-threatening conditions in the region." Mr.
Willman continued, "SafeTrace Tx will help CCPRC achieve its
continuing commitment to provide high quality blood products and
transfusion services to the patients served by its hospital
network." Gillie McCreath, Keane's National Account Executive,
added, "CCPRC selected the Keane Laboratory Information System
(LIS) to replace another vendor due to our product's robust
functionality and seamless integration with our other Keane
applications installed at CCPRC. We recommended Wyndgate to CCPRC
because of their ability to work well with Keane's laboratory
product, their expertise in this particular market, and their
resilient product." About Cardiovascular Center of Puerto Rico and
the Caribbean Founded in 1992, the Cardiovascular Center of Puerto
Rico and the Caribbean is the only hospital in the region
specializing in the diagnosis, treatment and surgery of
cardiovascular conditions. It is also the only institution in
Puerto Rico that performs cardiovascular surgery on adults and
children, including heart transplant procedures. CCPRC, located in
Rio Piedras, Puerto Rico, is a hospital with facilities for cardiac
catheterization, six operating rooms, clinical laboratories,
radiology, non-invasive laboratories, nuclear medicine and a
pharmacy. About Keane and Keane's Healthcare Solutions Division
(HSD) In business since 1965 and based in the United States, Keane
is a global services firm that specializes in enabling
transformation of its clients' business and IT functions. The
transformation partner of choice for clients across a broad array
of industries. Keane's Healthcare Solutions Division (HSD) provides
proprietary software and services to hospitals and long-term care
facilities throughout the country. Since 1975, Keane's software has
been helping clients increase efficiencies, reduce medical errors,
meet regulatory requirements, and enhance revenue cycle management.
Keane's core healthcare solutions include EZ-Access, Patcom, Keane
InSight, and Keane NetSolutions. Information about Keane HSD is
available on the Internet at http://www.keane.com/hsd. About Global
Med Technologies, Inc. Global Med Technologies(R), Inc. is an
international e-Health medical information technology company
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies(R) division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers. Each
year, Wyndgate's products and services manage more than eight
million blood components, representing over 27% of the U.S. blood
supply. Wyndgate's products are also being used in Canada and
sub-Saharan Africa, and are being implemented in the Caribbean.
Together, the Donor Doc(TM) interactive donor health history
questionnaire, SafeTrace(R) donor management system, and the
SafeTrace Tx(R) advanced transfusion management system, recently
patented, provide Vein-to-Vein(R) tracking from donor collection to
patient transfusion. For more information about Global Med's
products and services, please call 800-WYNDGATE or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/ and
http://www.wyndgate.com/. This news release may include statements
that constitute forward-looking statements, usually containing the
words "believe," "estimate," "project," "expects" or similar
expressions. These statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies(R),
Inc. CONTACT: investors, Paul Holm, , or H.L. Lanzet, , both for
Global Med Technologies(R), Inc., +1-212-888-4570; or Michael I.
Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000 Web
site: http://www.globalmedtech.com/ http://www.peoplemed.com/
http://www.wyndgate.com/ http://www.keane.com/hsd
Copyright